| Filed | Form | Description | |
|---|---|---|---|
| 5/16/25 | DEF 14A | DEF 14A | → |
| 5/6/25 | PRE 14A | PRE 14A | → |
| Filed | Form | Description | |
|---|---|---|---|
| 2/13/26 | 4 | OWNERSHIP DOCUMENT | → |
| 1/6/26 | 4 | 4 | → |
| 1/6/26 | 4 | 4 | → |
| 1/6/26 | 4 | 4 | → |
| 1/6/26 | 4 | 4 | → |
| 1/6/26 | 4 | 4 | → |
| ↓ | |||
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases.